STOCK TITAN

BeyondSpring Inc. (BYSI) Financials

BYSI
FY2025 annual
Revenue $0 YoY not available
Net Income -$1.0M +91.0% YoY
Free Cash Flow -$19.8M -18.9% YoY
Operating Cash Flow -$19.8M -20.2% YoY
Market Cap $28.5M as of Oct 6, 2026
Price / Sales n/m revenue is not positive, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BYSI SEC filings page.

BeyondSpring Inc. (BYSI) reported $0 in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BYSI FY2025

BeyondSpring’s development-stage model carries a liability-heavy balance sheet while research spending still greatly exceeds commercial revenue.

From FY2021 to FY2022, net loss narrowed from $64.2M to $33.3M. Operating cash outflow also narrowed from $47.2M to $27.5M, so the accounting improvement was accompanied by less cash consumption rather than revenue-led cash generation.

Revenue was only $1.4M in both valid years, while R&D reached $36.9M in FY2021. R&D remained $25.6M in FY2022, making the cost base many times larger than reported sales and showing that the business was still funding development ahead of commercialization.

By FY2022, total liabilities were $49.2M against $46.2M of assets, indicating a solvency imbalance rather than a conventional operating balance sheet. Equity stood at -$6.0M, while the supplied liquidity comparison equaled 7.6 months of latest annual operating outflow; short-term resources therefore do not erase the negative net-worth position.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

BeyondSpring Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-22.56

BeyondSpring Inc. scores -22.56, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($28.5M) relative to total liabilities ($58.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
1/7

BeyondSpring Inc. passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

BeyondSpring Inc. reported a net loss of $1.0M while operations used $19.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

BeyondSpring Inc. generated $0 in revenue in Q2 2026.

EBITDA
-$1.7M
YoY+8.3%
QoQ+22.6%

BeyondSpring Inc.'s EBITDA was -$1.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is up 22.6%.

Net Income
-$849K
YoY+53.0%
QoQ+60.7%

BeyondSpring Inc. reported -$849K in net income in Q2 2026. This represents an increase of 53.0% from the same quarter a year earlier. Against the prior quarter it is up 60.7%.

EPS (Diluted)
-$0.02

BeyondSpring Inc. earned -$0.02 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Free Cash Flow
-$3.8M
YoY+35.8%
QoQ-15.1%

BeyondSpring Inc. recorded an outflow of $3.8M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 35.8% from the same quarter a year earlier. Against the prior quarter it is down 15.1%.

Cash & Debt
$2.7M
YoY-71.7%
QoQ-33.2%
5Y CAGR-41.1%

BeyondSpring Inc. held $2.7M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
41M
QoQ0.0%

BeyondSpring Inc. had 41M shares outstanding in Q2 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

R&D Spending
$973K
YoY-2.9%
QoQ-9.6%

BeyondSpring Inc. invested $973K in research and development in Q2 2026. This represents a decrease of 2.9% from the same quarter a year earlier. Against the prior quarter it is down 9.6%.

Capital Expenditures
$0

BeyondSpring Inc. reported no capital expenditure in Q2 2026.

Share Buybacks

Not reported for Q2 2026.

BYSI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYSI quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$0$0N/A$0$0$0N/A$0
R&D Expenses$973K-2.9%$1.1M+23.1%N/A$1.0M+67.0%$1.0M+20.9%$874K+21.2%N/A$622K
SG&A Expenses$758K-20.0%$1.2M-33.4%N/A$751K-56.7%$947K-47.7%$1.7M+30.1%N/A$1.7M
Operating Income-$1.7M+11.2%-$2.2M+14.5%N/A-$1.8M+24.1%-$1.9M+26.2%-$2.6M-27.0%N/A-$2.4M
EBITDA-$1.7M+8.3%-$2.2M+12.5%N/A-$1.7M+24.9%-$1.9M+26.1%-$2.5M-27.3%N/A-$2.3M
Income Tax$100K+354.5%$192K+860.0%N/A$26K$22K$20KN/A$0
Net Income-$849K+53.0%-$2.2M-148.2%N/A-$1.5M+27.8%-$1.8M+55.2%$4.5M+238.6%N/A-$2.1M
EPS (Basic)-$0.02+50.0%-$0.05-145.5%-$0.05-25.0%-$0.04+20.0%-$0.04+60.0%$0.11+237.5%-$0.04-$0.05
EPS (Diluted)-$0.02N/AN/AN/A-$0.10N/AN/AN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense, Diluted Shares (Avg).

BYSI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYSI quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$14.6M-52.9%$18.4M-50.4%$25.9M-24.4%$29.5M$31.0M+48.6%$37.1M$34.3M+38.3%N/A
Current Assets$9.9M-61.5%$13.5M-57.2%$20.9M-26.9%$24.4M$25.7M+72.3%$31.5M$28.6M+55.1%N/A
Cash & Equivalents$2.7M-71.7%$4.0M-38.2%$7.8M+166.5%$12.5M-35.3%$9.5M+13.7%$6.5M+98.9%$2.9M-45.8%$19.3M
Short-Term Investments$3.8M$3.8M+91.3%$4.8M$141K$0-100.0%$2.0M$0-100.0%$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$50.6M-17.3%$52.9M-19.1%$58.1M-13.6%$61.3M$61.3M+29.9%$65.4M$67.2M+39.3%N/A
Current Liabilities$14.2M+21.0%$12.4M-2.3%$13.6M+23.3%$12.9M$11.7M+43.3%$12.7M$11.0M+38.4%N/A
Non-Current Liabilities$36.4M-1.1%$36.4M-1.9%$36.3M-3.3%$36.4M$36.9M-5.5%$37.1M$37.6M-6.8%N/A
Total Equity-$35.6M-17.7%-$34.5M-21.8%-$32.2M+2.2%-$31.8M-188.5%-$30.2M-0.1%-$28.3M+25.8%-$32.9M-22.7%-$11.0M
Retained Earnings-$411.4M-1.7%-$410.6M-1.9%-$408.4M-0.2%-$406.3M-$404.8M-0.3%-$402.9M-$407.4M-2.8%N/A

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

BYSI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYSI quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$3.8M+35.8%-$3.3M+21.9%-$5.5M-660.5%-$4.2M+18.9%-$5.9M+15.9%-$4.2M+20.3%$982K-$5.2M
Depreciation & Amortization$19K-76.8%$19K-76.3%-$156K-880.0%$81K-2.4%$82K-28.7%$80K+19.4%$20K$83K
Stock-Based CompensationN/A$461K+88.9%N/AN/AN/A$244K-2.8%N/AN/A
Capital Expenditures$0$0-100.0%$0-100.0%$0-100.0%$0$50K$27K$197K
Free Cash Flow-$3.8M+35.8%-$3.3M+22.9%-$5.5M-676.3%-$4.2M+21.9%-$5.9M+15.9%-$4.2M+19.4%$955K-$5.4M
Investing Cash Flow-$5K-100.0%$4.5M-28.9%-$5.1M+47.6%-$1.2M+44.5%$10.8M$6.3M-$9.8M-$2.2M
Financing Cash Flow-$74K-$4.2M$2.0M+6.9%$3.0M-86.3%$0$0$1.8M$21.9M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BYSI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BYSI quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-5.8%0.0pp-11.7%-23.8ppN/A-5.2%-5.8%+13.5pp12.1%N/AN/A
Current Ratio0.70-1.5x1.09-1.4x1.54-1.1x1.892.19+0.4x2.492.60+0.3xN/A
Asset Turnover0.000.0x0.000.0xN/A0.000.000.0x0.00N/AN/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.

Note: Shareholder equity is negative (-$32.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
BeyondSpring Inc. BYSI FY2025 $0 -$1.0M N/A $28.5M —
OS Therapies Incorporated OSTX FY2025 N/A -$28.8M N/A $74.9M —
Immix Biopharma, Inc. IMMX FY2025 N/A -$29.4M N/A $839.8M —
Aligos Therapeutics, Inc. ALGS FY2025 $2.2M -$24.2M N/A $33.7M 46/100
Adicet Bio, Inc. ACET FY2025 N/A -$116.8M N/A $60.6M —

Frequently Asked Questions

What is BeyondSpring Inc.'s annual revenue?

BeyondSpring Inc. (BYSI) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is BeyondSpring Inc. profitable?

No, BeyondSpring Inc. (BYSI) reported a net income of -$1.0M in fiscal year 2025.

What is BeyondSpring Inc.'s EBITDA?

BeyondSpring Inc. (BYSI) had EBITDA of -$8.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

BeyondSpring Inc. (BYSI) recorded an outflow of $19.8M in free cash flow during fiscal year 2025. This represents a -18.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

BeyondSpring Inc. (BYSI) recorded an outflow of $19.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

BeyondSpring Inc. (BYSI) had $25.9M in total assets as of fiscal year 2025, including both current and long-term assets.

BeyondSpring Inc. (BYSI) invested $50K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

BeyondSpring Inc. (BYSI) invested $4.4M in research and development during fiscal year 2025.

BeyondSpring Inc. (BYSI) had 41M shares outstanding as of fiscal year 2025.

BeyondSpring Inc. (BYSI) had a current ratio of 1.54 as of fiscal year 2025, which is generally considered healthy.

BeyondSpring Inc. (BYSI) had a return on assets of -3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

BeyondSpring Inc. (BYSI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $28.5M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

BeyondSpring Inc. (BYSI) has no price-to-sales ratio at the moment: revenue is not positive (FY2025). The market capitalization is $28.5M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, BeyondSpring Inc. (BYSI) held $12.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $19.8M over that year. Dividing the one by the other, the reported balance equals about 8 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

BeyondSpring Inc. (BYSI) has negative shareholder equity of -$32.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

BeyondSpring Inc. (BYSI) has an Altman Z-Score of -22.56, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

BeyondSpring Inc. (BYSI) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

BeyondSpring Inc. (BYSI) reported a net loss of $1.0M while operations used $19.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top